Cite Filings / FDMT / 0001193125-24-024196

Feed Companies Filings Check

Sign in

424B5

Prospectus

4D Molecular Therapeutics, Inc. Filed 2024-02-05 Acc 0001193125-24-024196

Documents 1

424B5 Prospectus , d724643d424b5.htm

Around this filing

2024-02-08 424B5 Prospectus
2024-02-07 FWP Free Writing Prospectus
2024-02-07 4 Chief Medical Officer sold 24,552 shares at $30.05 ($737,788)
2024-02-07 3/A 3/A
2024-02-05 424B5 Prospectus
2024-02-05 S-3ASR Registration Statement
2023-05-08 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d724643d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…